The news is a blow for Medtronic and investors, who expected big things from an experimental device that uses extreme heat to regulate heartbeat. Medtronic bought the company that developed the device for $225 million in 2009. The panel's recommendation isn't the final say, but the FDA will take it under consideration.
BB gun vandalism spree leaves trail of damage across St. Cloud
A teen thought to be involved has been identified, but police continue to investigate.